MDLN · NASDAQ
Medline Inc.
$34.08 -0.79 (-2.25%)
Company overview
Medline Inc. manufactures medical and surgical products serving hospitals, surgery centers, physician offices, post-acute facilities, and nursing homes in the United States and internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products across three categories: surgical solutions, front-line care, and laboratory and diagnostics. The front-line care offerings include wound care products, exam gloves, skin care and incontinence products, environmental cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $29.9B
- Employees
- 43,000
- Headquarters
- Northfield, IL
- Website
- medline.com
- CEO
- James Boyle
- Listed
- December 17, 2025
- P/E
- 28.17
- Dividend yield
- 0.00%
Company financials
- Revenue
- $29.1B
- Gross profit
- $7B
- Operating income
- $2.1B
- EBITDA
- $2.9B
- Net income
- $964M
- EPS
- $1.21
- Total assets
- $39B
- Total debt
- $12.6B
- Gross margin
- 24.04%
- Net margin
- 3.31%
- Earnings yield
- 3.55%
No product segmentation.
No annual segmentation.
MDLN
1D
NASDAQ
O34.85H35.03L33.63C34.88-0.43 (-1.22%)Vol14.96M